Industries > Food and Drink > Beta Glucan Market Report to 2031
Beta Glucan Market Report to 2031
Forecasts By Source (Cereals, Seaweed, Yeast, Mushroom), By Category (Soluble, Insoluble), By End-use Industries (Food & Beverages, Personal Care, Healthcare, Animal Feed), By Purity (Below 20%, 20% to 30%, 30% to 50%, 50% to 70%, Above 70%) PLUS Profiles of Leading Beta Glucan Manufacturing Companies and Regional and Leading National Market Analysis, PLUS COVID-19 Recovery Scenarios
Beta Glucan Market– our new study reveals trends, R&D progress, and predicted revenues
Where is the Beta Glucan Market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 655 page report provides 822 tables and 825 charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Beta Glucan Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Beta Glucan Market: by Source
• Cererals
• Seaweed
• Yeast
• Mushroom
Beta Glucan Market: by Category
• Soluble
• Insoluble
Beta Glucan Market: by End-use Industries
• Food & Beverages
• Personal Care
• Healthcare
• Animal Feed
Beta Glucan Market: by Purity
• Below 20%
• 20% to 30%
• 30% to 50%
• 50% to 70%
• Above 70%
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 22 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Netherlands
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Southeast Asia
o Rest of Asia Pacific
• South America
o Brazil
o Colombia
o Argentina
o Mexico
o Rest of Latin America
• Middle East & Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Beta Glucan Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Beta Glucan Market will surpass $ XX million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Beta Glucan Market report helps you
In summary, our 600+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Beta Glucan Market, with forecasts for Source, Category, End-use Industries, Purity, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2030 for 5 regional and 22 key national markets– See forecasts for the Beta Glucan Market in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Beta Glucan Market. Some of the company’s profiled in this report include Cargill Inc., Tate & Lyle Plc, Kerry Group Plc, Koninklijke DSM NV, and Frutarom Industries among others.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Beta Glucan Market Report to 2031: Forecasts By Source (Cereals, Seaweed, Yeast, Mushroom), By Category (Soluble, Insoluble), By End-use Industries (Food & Beverages, Personal Care, Healthcare, Animal Feed), By Purity (Below 20%, 20% to 30%, 30% to 50%, 50% to 70%, Above 70%) PLUS Profiles of Leading Beta Glucan Manufacturing Companies and Regional and Leading National Market Analysis, PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Beta Glucan Market
2.1. Beta Glucan Market Definition
2.2. Category Submarkets Definitions
2.3. Source Submarket Definitions
2.4. End-use Industries Submarkets Definitions
2.5. Purity Submarkets Definitions
3. Beta Glucan Market Overview
3.1. Global Beta Glucan Market Size and Forecast by Region
3.2. Global Beta Glucan Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Growing Healthcare Expenditure
3.3.1.2. Growing Availability of Raw Material for Beta Glucan
3.3.1.3. Growing Mushroom Cultivation in Asia Pacific
3.3.2. Market Restraints/Challenges
3.3.2.1. Strict Government Regulations Concerning Beta Glucan
3.3.2.2. High Extraction Costs
3.3.3. Opportunities
3.3.3.1. Growing Application base for Beta Glucan in Emerging Nations
3.3.4. Global Beta Glucan Market: Trends
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Beta Glucan Market Analysis and Forecast 2021-2031, by Purity (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Below 20%
4.1.2. 20% to 30%
4.1.3. 30% to 50%
4.1.4. 50% to 70%
4.1.5. Above 70%
5. Global Beta Glucan Market Analysis and Forecast, 2021-2031 by Category (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Soluble
5.1.2. In-soluble
6. Global Beta Glucan Market Analysis and Forecast, 2021-2031 by Source (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Cereal
6.1.1.1. High Production of Cereals Driving Market Growth for Beta Glucan
6.1.2. Seaweed
6.1.2.1. Low Molecular Complexity Associated with Extracting Beta Glucan from Seaweed
6.1.3. Yeast
6.1.3.1. High Availability of Yeast
6.1.4. Mushroom
6.1.4.1. Growing Mushroom Cultivation in Asia Pacific
7. Global Beta Glucan Market Analysis and Forecast, 2021-2031 by End-use Industries (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Food & Beverage
7.1.1.1. Growing Demand for Functional Food& Beverages in Emerging Nations
7.1.2. Personal Care
7.1.2.1. Promising Market Growth Personal Care Products in Emerging Nations
7.1.3. Healthcare
7.1.3.1. Growing Healthcare Expenditure
7.1.4. Animal Feed
7.1.4.1. Growing Livestock Production
8. North America Beta Glucan Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. North America Beta Glucan Market Size and Forecast by Purity
8.2.1. 20% to 30% Submarket Expected to Grow at Fastest Rate
8.3. North America Beta Glucan Market Size and Forecast by Category
8.3.1. Soluble Submarket to Grow at Fastest Rate
8.4. North America Beta Glucan Market Size and Forecast by Source
8.4.1. Cereals Submarket to Grow at Fastest Rate
8.5. North America Beta Glucan Market Size and Forecast by End-use Industries
8.5.1. Food & Beverages Submarket to Grow at Fastest Rate
8.6. U.S. Beta Glucan Market
8.7. Canada Beta Glucan Market
9. Europe Beta Glucan Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Europe Beta Glucan Market Size and Forecast by Purity
9.2.1. 30% to 50% Submarket Expected to Grow at Fastest Rate
9.3. Europe Beta Glucan Market Size and Forecast by Category
9.3.1. Soluble Submarket to Grow at Fastest Rate
9.4. Europe Beta Glucan Market Size and Forecast by Source
9.4.1. Yeast Submarket to Grow at Fastest Rate
9.5. Europe Beta Glucan Market Size and Forecast by End-use Industries
9.5.1. Food & Beverages Submarket to Grow at Fastest Rate
9.6. UK Beta Glucan Market
9.7. Germany Beta Glucan Market
9.8. France Beta Glucan Market
9.9. Italy Beta Glucan Market
9.10. Spain Beta Glucan Market
9.11. Russia Beta Glucan Market
9.12. Netherlands Beta Glucan Market
9.13. Rest of Europe Beta Glucan Market
10. Asia Pacific Beta Glucan Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Asia Pacific Beta Glucan Market Size and Forecast by Purity
10.2.1. 20% to 30% Submarket Expected to Grow at Fastest Rate
10.3. Asia Pacific Beta Glucan Market Size and Forecast by Category
10.3.1. Insoluble Submarket to Grow at Fastest Rate
10.4. Asia Pacific Beta Glucan Market Size and Forecast by Source
10.4.1. Mushroom Submarket to Grow at Fastest Rate
10.5. Asia Pacific Beta Glucan Market Size and Forecast by End-use Industries
10.5.1. Personal Care Submarket to Grow at Fastest Rate
10.6. China Beta Glucan Market
10.7. India Beta Glucan Market
10.8. Japan Beta Glucan Market
10.9. Australia Beta Glucan Market
10.10. South Korea Beta Glucan Market
10.11. Southeast Asia Beta Glucan Market
10.12. Rest of Asia Pacific Beta Glucan Market
11. Latin America Beta Glucan Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Latin America Beta Glucan Market Size and Forecast by Purity
11.2.1. Below 20% Submarket Expected to Grow at Fastest Rate
11.3. Latin America Beta Glucan Market Size and Forecast by Category
11.3.1. Soluble Submarket to Grow at Fastest Rate
11.4. Latin America Beta Glucan Market Size and Forecast by Source
11.4.1. Cereals Supplement Submarket to Grow at Fastest Rate
11.5. Latin America Beta Glucan Market Size and Forecast by End-use Industries
11.5.1. Healthcare Submarket to Grow at Fastest Rate
11.5.2. Brazil Beta Glucan Market
11.5.3. Colombia Beta Glucan Market
11.5.4. Argentina Beta Glucan Market
11.5.5. Mexico Beta Glucan Market
11.5.6. Rest of Latin America Beta Glucan Market
12. Middle East & Africa Beta Glucan Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Middle East & Africa Beta Glucan Market Size and Forecast by Purity
12.2.1. 20% to 30% Submarket Expected to Grow at Fastest Rate
12.3. Middle East & Africa Beta Glucan Market Size and Forecast by Category
12.3.1. Soluble Submarket to Grow at Fastest Rate
12.4. Middle East & Africa Beta Glucan Market Size and Forecast by Source
12.4.1. Cereals Submarket to Grow at Fastest Rate
12.5. Middle East & Africa Beta Glucan Market Size and Forecast by End-use Industries
12.5.1. Food & Beverage Submarket to Grow at Fastest Rate
12.5.2. Turkey Beta Glucan Market
12.5.3. Saudi Arabia Beta Glucan Market
12.5.4. South Africa Beta Glucan Market
12.5.5. UAE Beta Glucan Market
12.5.6. Egypt Beta Glucan Market
12.5.7. Rest of Middle East & Africa Beta Glucan Market
13. Companies in the Beta Glucan Market
13.1. Cargill Inc.
13.1.1. Company Snapshot
13.1.2. Company Overview
13.1.3. Financial Performance (2015-2019)
13.1.3.1. Net Revenue
13.1.3.2. Gross Profit
13.1.3.3. Geographical Revenue, 2019
13.1.4. Product Offerings
13.1.5. Recent Initiatives (2018-2020)
13.2. Tate & Lyle Plc
13.2.1. Company Snapshot
13.2.2. Company Overview
13.2.3. Financial Performance (2015-2019)
13.2.3.1. Net Revenue
13.2.3.2. Gross Profit
13.2.3.3. Geographical Revenue, 2019
13.2.4. Product Offerings
13.2.5. Recent Initiatives (2018-2020)
13.3. Kerry Group Plc
13.3.1. Company Snapshot
13.3.2. Company Overview
13.3.3. Financial Performance (2015-2019)
13.3.3.1. Net Revenue
13.3.3.2. Gross Profit
13.3.3.3. Geographical Revenue, 2019
13.3.4. Product Offerings
13.3.5. Recent Initiatives (2018-2020)
13.4. Koninklijke DSM NV
13.4.1. Company Snapshot
13.4.2. Company Overview
13.4.3. Financial Performance (2015-2019)
13.4.3.1. Net Revenue
13.4.3.2. Gross Profit
13.4.3.3. Geographical Revenue, 2019
13.4.4. Product Offerings
13.4.5. Recent Initiatives (2018-2020)
13.5. Frutarom
13.5.1. Company Snapshot
13.5.2. Company Overview
13.5.3. Financial Performance (2015-2019)
13.5.3.1. Net Revenue
13.5.3.2. Gross Profit
13.5.3.3. Geographical Revenue, 2019
13.5.4. Product Offerings
13.5.5. Recent Initiatives (2018-2020)
13.6. Garuda International Inc.
13.6.1. Company Snapshot
13.6.2. Company Overview
13.6.3. Financial Performance (2015-2019)
13.6.3.1. Net Revenue
13.6.3.2. Gross Profit
13.6.3.3. Geographical Revenue, 2019
13.6.4. Product Offerings
13.6.5. Recent Initiatives (2018-2020)
13.7. Ohly
13.7.1. Company Snapshot
13.7.2. Company Overview
13.7.3. Financial Performance (2015-2019)
13.7.3.1. Net Revenue
13.7.3.2. Gross Profit
13.7.3.3. Geographical Revenue, 2019
13.7.4. Product Offerings
13.7.5. Recent Initiatives (2018-2020)
13.8. Milipore Sigma
13.8.1. Company Snapshot
13.8.2. Company Overview
13.8.3. Financial Performance (2015-2019)
13.8.3.1. Net Revenue
13.8.3.2. Gross Profit
13.8.3.3. Geographical Revenue, 2019
13.8.4. Product Offerings
13.8.5. Recent Initiatives (2018-2020)
13.9. Super Beta Glucan
13.9.1. Company Snapshot
13.9.2. Company Overview
13.9.3. Financial Performance (2015-2019)
13.9.3.1. Net Revenue
13.9.3.2. Gross Profit
13.9.3.3. Geographical Revenue, 2019
13.9.4. Product Offerings
13.9.5. Recent Initiatives (2018-2020)
13.10. Alltech Inc.
13.10.1. Company Snapshot
13.10.2. Company Overview
13.10.3. Financial Performance (2015-2019)
13.10.3.1. Net Revenue
13.10.3.2. Gross Profit
13.10.3.3. Geographical Revenue, 2019
13.10.4. Product Offerings
13.10.5. Recent Initiatives (2018-2020)
13.11. Other Notable Players
14. Conclusion
15. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Purity
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation Purity
LIST OF TABLES
Table 1. Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Beta Glucan Market Drivers & Restraints 2021
Table 7. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 38. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 53. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 78. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Regional Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. Regional Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Regional Beta Glucan Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Regional Beta Glucan Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Regional Beta Glucan Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 223. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 224. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 225. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 226. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 227. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 228. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 229. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 230. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 231. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 232. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 233. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 234. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 235. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 236. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 237. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 238. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 239. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 240. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 241. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 242. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 243. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 244. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 245. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 246. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 247. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 248. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 249. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 250. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 251. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 252. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 253. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 254. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 255. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 256. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 257. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 258. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 259. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 260. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 261. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 262. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 263. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 264. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 265. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 266. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 267. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 268. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 269. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 270. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 271. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 272. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 273. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 274. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 275. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 276. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 277. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 278. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 279. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 280. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 281. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 282. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 283. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 284. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 285. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 286. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 287. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 288. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 289. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 290. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 291. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 292. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 293. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 294. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 295. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 296. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 297. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 298. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 299. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 300. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 301. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 302. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 303. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 304. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 305. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 306. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 307. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 308. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 309. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 310. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 311. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 312. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 313. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 314. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 315. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 316. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 317. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 318. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 319. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 320. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 321. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 322. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 323. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 324. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 325. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 326. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 327. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 328. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 329. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 330. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 331. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 332. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 333. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 334. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 335. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 336. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 337. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 338. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 339. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 340. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 341. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 342. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 343. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 344. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 345. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 346. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 347. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 348. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 349. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 350. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 351. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 352. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 353. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 354. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 355. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 356. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 357. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 358. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 359. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 360. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 361. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 362. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 363. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 364. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 365. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 366. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 367. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 368. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 369. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 370. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 371. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 372. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 373. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 374. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 375. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 376. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 377. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 378. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 379. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 380. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 381. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 382. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 383. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 384. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 385. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 386. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 387. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 388. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 389. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 390. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 391. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 392. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 393. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 394. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 395. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 396. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 397. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 398. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 399. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 400. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 401. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 402. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 403. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 404. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 405. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 406. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 407. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 408. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 409. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 410. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 411. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 412. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 413. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 414. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 415. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 416. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 417. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 418. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 419. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 420. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 421. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 422. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 423. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 424. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 425. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 426. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 427. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 428. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 429. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 430. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 431. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 432. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 433. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 434. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 435. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 436. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 437. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 438. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 439. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 440. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 441. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 442. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 443. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 444. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 445. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 446. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 447. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 448. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 449. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 450. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 451. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 452. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 453. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 454. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 455. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 456. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 457. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 458. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 459. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 460. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 461. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 462. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 463. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 464. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 465. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 466. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 467. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 468. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 469. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 470. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 471. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 472. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 473. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 474. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 475. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 476. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 477. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 478. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 479. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 480. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 481. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 482. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 483. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 484. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 485. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 486. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 487. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 488. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 489. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 490. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 491. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 492. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 493. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 494. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 495. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 496. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 497. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 498. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 499. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 500. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 501. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 502. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 503. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 504. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 505. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 506. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 507. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 508. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 509. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 510. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 511. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 512. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 513. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 514. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 515. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 516. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 517. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 518. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 519. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 520. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 521. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 522. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 523. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 524. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 525. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 526. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 527. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 528. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 529. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 530. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 531. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 532. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 533. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 534. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 535. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 536. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 537. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 538. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 539. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 540. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 541. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 542. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 543. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 544. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 545. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 546. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 547. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 548. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 549. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 550. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 551. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 552. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 553. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 554. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 555. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 556. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 557. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 558. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 559. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 560. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 561. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 562. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 563. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 564. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 565. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 566. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 567. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 568. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 569. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 570. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 571. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 572. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 573. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 574. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 575. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 576. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 577. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 578. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 579. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 580. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 581. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 582. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 583. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 584. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 585. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 586. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 587. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 588. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 589. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 590. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 591. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 592. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 593. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 594. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 595. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 596. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 597. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 598. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 599. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 600. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 601. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 602. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 603. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 604. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 605. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 606. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 607. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 608. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 609. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 610. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 611. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 612. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 613. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 614. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 615. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 616. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 617. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 618. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 619. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 620. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 621. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 622. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 623. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 624. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 625. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 626. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 627. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 628. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 629. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 630. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 631. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 632. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 633. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 634. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 635. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 636. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 637. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 638. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 639. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 640. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 641. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 642. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 643. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 644. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 645. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 646. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 647. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 648. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 649. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 650. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 651. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 652. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 653. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 654. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 655. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 656. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 657. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 658. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 659. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 660. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 661. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 662. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 663. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 664. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 665. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 666. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 667. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 668. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 669. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 670. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 671. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 672. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 673. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 674. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 675. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 676. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 677. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 678. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 679. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 680. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 681. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 682. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 683. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 684. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 685. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 686. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 687. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 688. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 689. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 690. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 691. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 692. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 693. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 694. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 695. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 696. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 697. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 698. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 699. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 700. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 701. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 702. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 703. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 704. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 705. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 706. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 707. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 708. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 709. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 710. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 711. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 712. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 713. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 714. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 715. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 716. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 717. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 718. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 719. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 720. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 721. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 722. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 723. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 724. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 725. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 726. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 727. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 728. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 729. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 730. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 731. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 732. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 733. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 734. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 735. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 736. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 737. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 738. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 739. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 740. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 741. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 742. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 743. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 744. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 745. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 746. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 747. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 748. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 749. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 750. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 751. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 752. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 753. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 754. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 755. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 756. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 757. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 758. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 759. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 760. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 761. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 762. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 763. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 764. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 765. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 766. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 767. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 768. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 769. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 770. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 771. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 772. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 773. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 774. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 775. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 776. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 777. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 778. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 779. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 780. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 781. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 782. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 783. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 784. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 785. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 786. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 787. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 788. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 789. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 790. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 791. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 792. Leading 10 Beta Glucan Companies (Ranking, Company, Latest Total Company Sales US$M, HQ)
Table 793. Cargill Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 794. Cargill Inc. Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 795. Cargill Inc. Beta Glucan Product Offering (Segment, Product Offerings)
Table 796. Tate & Lyle Plc Profile 2019 (CEO, HQ, Founded, Website)
Table 797. Tate & Lyle Plc Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 798. Tate & Lyle Plc Beta Glucan Product Offering (Segment, Product Offerings)
Table 799. Kerry Group Plc Profile 2019 (CEO, HQ, Founded, Website)
Table 800. Kerry Group Plc Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 801. Kerry Group Plc Beta Glucan Product Offering (Segment, Product Offerings)
Table 802. Koninklijke DSM NV Profile 2019 (CEO, HQ, Founded, Website)
Table 803. Koninklijke DSM NV Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 804. Koninklijke DSM NV Beta Glucan Product Offering (Segment, Product Offerings)
Table 805. Frutarom Profile 2019 (CEO, HQ, Founded, Website)
Table 806. Frutarom Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 807. Frutarom Beta Glucan Product Offering (Segment, Product Offerings)
Table 808. Garuda International Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 809. Garuda International Inc. Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 810. Garuda International Inc. Beta Glucan Product Offering (Segment, Product Offerings)
Table 811. Ohly Profile 2019 (CEO, HQ, Founded, Website)
Table 812. Ohly Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 813. Ohly Beta Glucan Product Offering (Segment, Product Offerings)
Table 814. Milipore Sigma Profile 2019 (CEO, HQ, Founded, Website)
Table 815. Milipore Sigma Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 816. Milipore Sigma Beta Glucan Product Offering (Segment, Product Offerings)
Table 817. Super Beta Glucan Profile 2019 (CEO, HQ, Founded, Website)
Table 818. Super Beta Glucan Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 819. Super Beta Glucan Beta Glucan Product Offering (Segment, Product Offerings)
Table 820. Alltech Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 821. Alltech Inc. Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 822. Alltech Inc. Beta Glucan Product Offering (Segment, Product Offerings)
LIST OF FIGURES
Figure 1. Beta Glucan Market Purity Overview
Figure 2. Beta Glucan Market Category Overview
Figure 3. Beta Glucan Market Source Overview
Figure 4. Beta Glucan Market End-use Industries Overview
Figure 5. Beta Glucan Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 6. Beta Glucan Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 7. Beta Glucan Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 8. Beta Glucan Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 9. Beta Glucan Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 10. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 11. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 12. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 13. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 14. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 15. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 16. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 17. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 18. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 19. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 20. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 21. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 22. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 23. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 24. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 25. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 26. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 27. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 28. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 29. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 30. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 31. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 32. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 33. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 34. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 35. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 36. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 37. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 38. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 39. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 40. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 41. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 42. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 43. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 44. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 45. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 46. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 47. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 48. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 49. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 50. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 51. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 52. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 53. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 54. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 55. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 56. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 57. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 58. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 59. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 60. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 61. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 62. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 63. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 64. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 65. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 66. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 67. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 68. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 69. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 70. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 71. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 72. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 73. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 74. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 75. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 76. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 77. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 78. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 79. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 80. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 81. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 82. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 83. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 84. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 85. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 86. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 87. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 88. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 89. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 90. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 91. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 92. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 93. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 94. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 95. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 96. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 97. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 98. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 99. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 100. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 101. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 102. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 103. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 104. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 105. Regional Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 106. Regional Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 107. Regional Beta Glucan Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 108. Regional Beta Glucan Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 109. Regional Beta Glucan Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 110. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 111. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 112. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 113. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 114. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 115. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 116. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 117. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 118. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 119. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 120. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 121. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 122. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 123. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 124. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 125. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 126. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 127. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 128. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 129. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 130. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 131. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 132. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 133. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 134. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 135. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 136. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 137. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 138. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 139. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 140. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 141. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 142. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 143. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 144. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 145. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 146. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 147. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 148. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 149. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 150. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 151. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 152. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 153. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 154. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 155. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 156. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 157. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 158. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 159. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 160. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 161. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 162. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 163. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 164. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 165. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 166. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 167. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 168. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 169. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 170. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 171. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 172. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 173. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 174. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 175. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 176. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 177. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 178. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 179. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 180. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 181. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 182. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 183. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 184. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 185. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 186. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 187. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 188. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 189. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 190. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 191. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 192. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 193. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 194. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 195. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 196. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 197. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 198. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 199. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 200. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 201. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 202. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 203. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 204. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 205. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 206. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 207. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 208. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 209. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 210. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 211. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 212. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 213. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 214. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 215. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 216. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 217. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 218. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 219. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 220. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 221. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 222. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 223. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 224. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 225. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 226. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 227. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 228. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 229. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 230. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 231. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 232. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 233. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 234. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 235. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 236. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 237. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 238. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 239. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 240. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 241. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 242. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 243. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 244. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 245. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 246. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 247. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 248. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 249. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 250. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 251. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 252. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 253. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 254. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 255. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 256. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 257. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 258. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 259. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 260. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 261. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 262. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 263. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 264. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 265. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 266. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 267. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 268. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 269. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 270. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 271. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 272. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 273. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 274. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 275. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 276. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 277. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 278. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 279. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 280. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 281. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 282. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 283. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 284. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 285. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 286. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 287. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 288. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 289. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 290. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 291. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 292. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 293. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 294. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 295. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 296. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 297. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 298. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 299. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 300. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 301. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 302. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 303. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 304. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 305. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 306. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 307. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 308. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 309. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 310. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 311. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 312. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 313. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 314. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 315. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 316. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 317. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 318. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 319. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 320. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 321. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 322. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 323. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 324. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 325. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 326. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 327. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 328. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 329. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 330. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 331. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 332. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 333. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 334. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 335. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 336. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 337. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 338. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 339. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 340. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 341. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 342. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 343. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 344. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 345. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 346. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 347. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 348. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 349. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 350. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 351. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 352. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 353. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 354. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 355. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 356. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 357. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 358. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 359. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 360. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 361. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 362. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 363. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 364. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 365. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 366. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 367. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 368. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 369. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 370. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 371. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 372. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 373. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 374. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 375. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 376. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 377. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 378. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 379. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 380. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 381. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 382. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 383. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 384. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 385. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 386. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 387. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 388. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 389. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 390. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 391. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 392. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 393. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 394. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 395. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 396. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 397. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 398. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 399. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 400. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 401. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 402. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 403. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 404. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 405. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 406. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 407. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 408. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 409. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 410. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 411. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 412. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 413. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 414. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 415. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 416. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 417. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 418. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 419. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 420. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 421. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 422. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 423. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 424. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 425. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 426. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 427. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 428. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 429. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 430. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 431. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 432. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 433. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 434. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 435. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 436. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 437. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 438. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 439. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 440. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 441. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 442. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 443. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 444. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 445. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 446. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 447. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 448. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 449. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 450. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 451. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 452. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 453. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 454. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 455. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 456. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 457. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 458. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 459. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 460. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 461. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 462. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 463. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 464. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 465. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 466. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 467. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 468. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 469. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 470. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 471. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 472. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 473. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 474. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 475. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 476. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 477. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 478. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 479. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 480. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 481. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 482. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 483. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 484. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 485. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 486. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 487. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 488. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 489. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 490. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 491. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 492. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 493. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 494. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 495. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 496. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 497. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 498. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 499. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 500. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 501. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 502. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 503. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 504. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 505. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 506. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 507. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 508. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 509. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 510. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 511. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 512. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 513. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 514. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 515. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 516. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 517. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 518. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 519. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 520. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 521. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 522. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 523. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 524. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 525. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 526. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 527. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 528. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 529. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 530. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 531. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 532. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 533. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 534. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 535. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 536. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 537. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 538. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 539. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 540. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 541. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 542. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 543. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 544. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 545. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 546. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 547. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 548. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 549. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 550. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 551. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 552. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 553. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 554. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 555. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 556. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 557. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 558. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 559. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 560. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 561. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 562. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 563. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 564. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 565. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 566. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 567. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 568. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 569. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 570. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 571. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 572. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 573. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 574. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 575. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 576. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 577. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 578. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 579. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 580. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 581. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 582. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 583. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 584. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 585. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 586. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 587. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 588. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 589. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 590. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 591. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 592. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 593. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 594. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 595. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 596. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 597. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 598. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 599. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 600. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 601. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 602. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 603. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 604. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 605. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 606. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 607. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 608. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 609. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 610. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 611. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 612. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 613. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 614. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 615. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 616. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 617. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 618. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 619. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 620. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 621. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 622. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 623. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 624. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 625. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 626. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 627. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 628. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 629. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 630. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 631. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 632. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 633. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 634. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 635. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 636. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 637. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 638. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 639. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 640. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 641. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 642. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 643. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 644. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 645. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 646. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 647. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 648. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 649. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 650. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 651. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 652. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 653. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 654. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 655. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 656. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 657. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 658. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 659. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 660. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 661. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 662. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 663. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 664. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 665. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 666. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 667. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 668. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 669. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 670. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 671. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 672. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 673. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 674. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 675. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 676. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 677. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 678. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 679. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 680. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 681. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 682. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 683. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 684. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 685. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 686. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 687. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 688. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 689. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 690. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 691. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 692. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 693. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 694. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 695. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 696. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 697. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 698. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 699. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 700. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 701. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 702. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 703. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 704. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 705. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 706. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 707. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 708. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 709. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 710. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 711. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 712. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 713. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 714. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 715. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 716. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 717. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 718. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 719. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 720. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 721. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 722. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 723. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 724. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 725. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 726. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 727. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 728. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 729. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 730. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 731. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 732. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 733. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 734. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 735. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 736. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 737. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 738. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 739. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 740. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 741. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 742. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 743. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 744. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 745. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 746. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 747. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 748. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 749. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 750. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 751. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 752. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 753. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 754. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 755. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 756. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 757. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 758. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 759. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 760. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 761. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 762. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 763. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 764. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 765. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 766. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 767. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 768. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 769. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 770. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 771. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 772. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 773. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 774. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 775. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 776. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 777. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 778. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 779. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 780. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 781. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 782. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 783. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 784. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 785. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 786. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 787. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 788. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 789. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 790. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 791. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 792. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 793. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 794. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 795. Porter’s Five Force Analysis
Figure 796. Cargill Inc. Total Company Sales 2015-2019 (US$m, AGR %)
Figure 797. Cargill Inc. Sales by Segment of Business 2019 (US$m)
Figure 798. Cargill Inc. Sales by Regional Segment of Business 2019 (US$m)
Figure 799. Tate & Lyle Plc Total Company Sales 2015-2019 (US$m, AGR %)
Figure 800. Tate & Lyle Plc Sales by Segment of Business 2019 (US$m)
Figure 801. Tate & Lyle Plc Sales by Regional Segment of Business 2019 (US$m)
Figure 802. Kerry Group Plc Total Company Sales 2015-2019 (US$m, AGR %)
Figure 803. Kerry Group Plc Sales by Segment of Business 2019 (US$m)
Figure 804. Kerry Group Plc Sales by Regional Segment of Business 2019 (US$m)
Figure 805. Koninklijke DSM NV Total Company Sales 2015-2019 (US$m, AGR %)
Figure 806. Koninklijke DSM NV Sales by Segment of Business 2019 (US$m)
Figure 807. Koninklijke DSM NV Sales by Regional Segment of Business 2019 (US$m)
Figure 808. Frutarom Total Company Sales 2015-2019 (US$m, AGR %)
Figure 809. Frutarom Sales by Segment of Business 2019 (US$m)
Figure 810. Frutarom Sales by Regional Segment of Business 2019 (US$m)
Figure 811. Garuda International Inc. Total Company Sales 2015-2019 (US$m, AGR %)
Figure 812. Garuda International Inc. Sales by Segment of Business 2019 (US$m)
Figure 813. Garuda International Inc. Sales by Regional Segment of Business 2019 (US$m)
Figure 814. Ohly Total Company Sales 2015-2019 (US$m, AGR %)
Figure 815. Ohly Sales by Segment of Business 2019 (US$m)
Figure 816. Ohly Sales by Regional Segment of Business 2019 (US$m)
Figure 817. Milipore Sigma Total Company Sales 2015-2019 (US$m, AGR %)
Figure 818. Milipore Sigma Sales by Segment of Business 2019 (US$m)
Figure 819. Milipore Sigma Sales by Regional Segment of Business 2019 (US$m)
Figure 820. Super Beta Glucan Total Company Sales 2015-2019 (US$m, AGR %)
Figure 821. Super Beta Glucan Sales by Segment of Business 2019 (US$m)
Figure 822. Super Beta Glucan Sales by Regional Segment of Business 2019 (US$m)
Figure 823. Alltech Inc. Total Company Sales 2015-2019 (US$m, AGR %)
Figure 824. Alltech Inc. Sales by Segment of Business 2019 (US$m)
Figure 825. Alltech Inc. Sales by Regional Segment of Business 2019 (US$m)
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Beta Glucan Market
2.1. Beta Glucan Market Definition
2.2. Category Submarkets Definitions
2.3. Source Submarket Definitions
2.4. End-use Industries Submarkets Definitions
2.5. Purity Submarkets Definitions
3. Beta Glucan Market Overview
3.1. Global Beta Glucan Market Size and Forecast by Region
3.2. Global Beta Glucan Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Growing Healthcare Expenditure
3.3.1.2. Growing Availability of Raw Material for Beta Glucan
3.3.1.3. Growing Mushroom Cultivation in Asia Pacific
3.3.2. Market Restraints/Challenges
3.3.2.1. Strict Government Regulations Concerning Beta Glucan
3.3.2.2. High Extraction Costs
3.3.3. Opportunities
3.3.3.1. Growing Application base for Beta Glucan in Emerging Nations
3.3.4. Global Beta Glucan Market: Trends
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Beta Glucan Market Analysis and Forecast 2021-2031, by Purity (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Below 20%
4.1.2. 20% to 30%
4.1.3. 30% to 50%
4.1.4. 50% to 70%
4.1.5. Above 70%
5. Global Beta Glucan Market Analysis and Forecast, 2021-2031 by Category (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Soluble
5.1.2. In-soluble
6. Global Beta Glucan Market Analysis and Forecast, 2021-2031 by Source (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Cereal
6.1.1.1. High Production of Cereals Driving Market Growth for Beta Glucan
6.1.2. Seaweed
6.1.2.1. Low Molecular Complexity Associated with Extracting Beta Glucan from Seaweed
6.1.3. Yeast
6.1.3.1. High Availability of Yeast
6.1.4. Mushroom
6.1.4.1. Growing Mushroom Cultivation in Asia Pacific
7. Global Beta Glucan Market Analysis and Forecast, 2021-2031 by End-use Industries (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.1.1. Food & Beverage
7.1.1.1. Growing Demand for Functional Food& Beverages in Emerging Nations
7.1.2. Personal Care
7.1.2.1. Promising Market Growth Personal Care Products in Emerging Nations
7.1.3. Healthcare
7.1.3.1. Growing Healthcare Expenditure
7.1.4. Animal Feed
7.1.4.1. Growing Livestock Production
8. North America Beta Glucan Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. North America Beta Glucan Market Size and Forecast by Purity
8.2.1. 20% to 30% Submarket Expected to Grow at Fastest Rate
8.3. North America Beta Glucan Market Size and Forecast by Category
8.3.1. Soluble Submarket to Grow at Fastest Rate
8.4. North America Beta Glucan Market Size and Forecast by Source
8.4.1. Cereals Submarket to Grow at Fastest Rate
8.5. North America Beta Glucan Market Size and Forecast by End-use Industries
8.5.1. Food & Beverages Submarket to Grow at Fastest Rate
8.6. U.S. Beta Glucan Market
8.7. Canada Beta Glucan Market
9. Europe Beta Glucan Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Europe Beta Glucan Market Size and Forecast by Purity
9.2.1. 30% to 50% Submarket Expected to Grow at Fastest Rate
9.3. Europe Beta Glucan Market Size and Forecast by Category
9.3.1. Soluble Submarket to Grow at Fastest Rate
9.4. Europe Beta Glucan Market Size and Forecast by Source
9.4.1. Yeast Submarket to Grow at Fastest Rate
9.5. Europe Beta Glucan Market Size and Forecast by End-use Industries
9.5.1. Food & Beverages Submarket to Grow at Fastest Rate
9.6. UK Beta Glucan Market
9.7. Germany Beta Glucan Market
9.8. France Beta Glucan Market
9.9. Italy Beta Glucan Market
9.10. Spain Beta Glucan Market
9.11. Russia Beta Glucan Market
9.12. Netherlands Beta Glucan Market
9.13. Rest of Europe Beta Glucan Market
10. Asia Pacific Beta Glucan Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Asia Pacific Beta Glucan Market Size and Forecast by Purity
10.2.1. 20% to 30% Submarket Expected to Grow at Fastest Rate
10.3. Asia Pacific Beta Glucan Market Size and Forecast by Category
10.3.1. Insoluble Submarket to Grow at Fastest Rate
10.4. Asia Pacific Beta Glucan Market Size and Forecast by Source
10.4.1. Mushroom Submarket to Grow at Fastest Rate
10.5. Asia Pacific Beta Glucan Market Size and Forecast by End-use Industries
10.5.1. Personal Care Submarket to Grow at Fastest Rate
10.6. China Beta Glucan Market
10.7. India Beta Glucan Market
10.8. Japan Beta Glucan Market
10.9. Australia Beta Glucan Market
10.10. South Korea Beta Glucan Market
10.11. Southeast Asia Beta Glucan Market
10.12. Rest of Asia Pacific Beta Glucan Market
11. Latin America Beta Glucan Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Latin America Beta Glucan Market Size and Forecast by Purity
11.2.1. Below 20% Submarket Expected to Grow at Fastest Rate
11.3. Latin America Beta Glucan Market Size and Forecast by Category
11.3.1. Soluble Submarket to Grow at Fastest Rate
11.4. Latin America Beta Glucan Market Size and Forecast by Source
11.4.1. Cereals Supplement Submarket to Grow at Fastest Rate
11.5. Latin America Beta Glucan Market Size and Forecast by End-use Industries
11.5.1. Healthcare Submarket to Grow at Fastest Rate
11.5.2. Brazil Beta Glucan Market
11.5.3. Colombia Beta Glucan Market
11.5.4. Argentina Beta Glucan Market
11.5.5. Mexico Beta Glucan Market
11.5.6. Rest of Latin America Beta Glucan Market
12. Middle East & Africa Beta Glucan Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
12.1. Market Overview
12.2. Middle East & Africa Beta Glucan Market Size and Forecast by Purity
12.2.1. 20% to 30% Submarket Expected to Grow at Fastest Rate
12.3. Middle East & Africa Beta Glucan Market Size and Forecast by Category
12.3.1. Soluble Submarket to Grow at Fastest Rate
12.4. Middle East & Africa Beta Glucan Market Size and Forecast by Source
12.4.1. Cereals Submarket to Grow at Fastest Rate
12.5. Middle East & Africa Beta Glucan Market Size and Forecast by End-use Industries
12.5.1. Food & Beverage Submarket to Grow at Fastest Rate
12.5.2. Turkey Beta Glucan Market
12.5.3. Saudi Arabia Beta Glucan Market
12.5.4. South Africa Beta Glucan Market
12.5.5. UAE Beta Glucan Market
12.5.6. Egypt Beta Glucan Market
12.5.7. Rest of Middle East & Africa Beta Glucan Market
13. Companies in the Beta Glucan Market
13.1. Cargill Inc.
13.1.1. Company Snapshot
13.1.2. Company Overview
13.1.3. Financial Performance (2015-2019)
13.1.3.1. Net Revenue
13.1.3.2. Gross Profit
13.1.3.3. Geographical Revenue, 2019
13.1.4. Product Offerings
13.1.5. Recent Initiatives (2018-2020)
13.2. Tate & Lyle Plc
13.2.1. Company Snapshot
13.2.2. Company Overview
13.2.3. Financial Performance (2015-2019)
13.2.3.1. Net Revenue
13.2.3.2. Gross Profit
13.2.3.3. Geographical Revenue, 2019
13.2.4. Product Offerings
13.2.5. Recent Initiatives (2018-2020)
13.3. Kerry Group Plc
13.3.1. Company Snapshot
13.3.2. Company Overview
13.3.3. Financial Performance (2015-2019)
13.3.3.1. Net Revenue
13.3.3.2. Gross Profit
13.3.3.3. Geographical Revenue, 2019
13.3.4. Product Offerings
13.3.5. Recent Initiatives (2018-2020)
13.4. Koninklijke DSM NV
13.4.1. Company Snapshot
13.4.2. Company Overview
13.4.3. Financial Performance (2015-2019)
13.4.3.1. Net Revenue
13.4.3.2. Gross Profit
13.4.3.3. Geographical Revenue, 2019
13.4.4. Product Offerings
13.4.5. Recent Initiatives (2018-2020)
13.5. Frutarom
13.5.1. Company Snapshot
13.5.2. Company Overview
13.5.3. Financial Performance (2015-2019)
13.5.3.1. Net Revenue
13.5.3.2. Gross Profit
13.5.3.3. Geographical Revenue, 2019
13.5.4. Product Offerings
13.5.5. Recent Initiatives (2018-2020)
13.6. Garuda International Inc.
13.6.1. Company Snapshot
13.6.2. Company Overview
13.6.3. Financial Performance (2015-2019)
13.6.3.1. Net Revenue
13.6.3.2. Gross Profit
13.6.3.3. Geographical Revenue, 2019
13.6.4. Product Offerings
13.6.5. Recent Initiatives (2018-2020)
13.7. Ohly
13.7.1. Company Snapshot
13.7.2. Company Overview
13.7.3. Financial Performance (2015-2019)
13.7.3.1. Net Revenue
13.7.3.2. Gross Profit
13.7.3.3. Geographical Revenue, 2019
13.7.4. Product Offerings
13.7.5. Recent Initiatives (2018-2020)
13.8. Milipore Sigma
13.8.1. Company Snapshot
13.8.2. Company Overview
13.8.3. Financial Performance (2015-2019)
13.8.3.1. Net Revenue
13.8.3.2. Gross Profit
13.8.3.3. Geographical Revenue, 2019
13.8.4. Product Offerings
13.8.5. Recent Initiatives (2018-2020)
13.9. Super Beta Glucan
13.9.1. Company Snapshot
13.9.2. Company Overview
13.9.3. Financial Performance (2015-2019)
13.9.3.1. Net Revenue
13.9.3.2. Gross Profit
13.9.3.3. Geographical Revenue, 2019
13.9.4. Product Offerings
13.9.5. Recent Initiatives (2018-2020)
13.10. Alltech Inc.
13.10.1. Company Snapshot
13.10.2. Company Overview
13.10.3. Financial Performance (2015-2019)
13.10.3.1. Net Revenue
13.10.3.2. Gross Profit
13.10.3.3. Geographical Revenue, 2019
13.10.4. Product Offerings
13.10.5. Recent Initiatives (2018-2020)
13.11. Other Notable Players
14. Conclusion
15. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Purity
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation Purity
LIST OF TABLES
Table 1. Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Beta Glucan Market Drivers & Restraints 2021
Table 7. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 38. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 53. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 58. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 78. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 88. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Regional Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. Regional Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Regional Beta Glucan Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Regional Beta Glucan Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Regional Beta Glucan Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 223. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 224. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 225. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 226. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 227. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 228. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 229. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 230. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 231. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 232. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 233. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 234. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 235. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 236. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 237. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 238. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 239. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 240. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 241. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 242. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 243. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 244. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 245. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 246. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 247. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 248. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 249. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 250. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 251. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 252. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 253. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 254. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 255. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 256. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 257. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 258. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 259. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 260. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 261. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 262. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 263. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 264. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 265. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 266. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 267. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 268. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 269. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 270. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 271. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 272. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 273. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 274. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 275. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 276. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 277. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 278. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 279. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 280. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 281. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 282. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 283. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 284. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 285. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 286. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 287. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 288. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 289. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 290. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 291. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 292. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 293. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 294. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 295. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 296. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 297. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 298. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 299. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 300. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 301. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 302. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 303. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 304. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 305. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 306. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 307. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 308. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 309. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 310. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 311. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 312. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 313. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 314. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 315. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 316. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 317. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 318. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 319. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 320. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 321. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 322. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 323. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 324. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 325. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 326. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 327. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 328. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 329. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 330. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 331. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 332. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 333. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 334. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 335. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 336. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 337. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 338. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 339. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 340. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 341. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 342. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 343. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 344. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 345. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 346. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 347. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 348. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 349. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 350. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 351. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 352. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 353. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 354. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 355. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 356. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 357. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 358. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 359. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 360. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 361. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 362. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 363. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 364. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 365. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 366. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 367. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 368. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 369. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 370. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 371. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 372. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 373. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 374. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 375. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 376. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 377. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 378. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 379. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 380. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 381. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 382. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 383. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 384. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 385. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 386. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 387. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 388. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 389. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 390. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 391. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 392. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 393. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 394. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 395. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 396. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 397. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 398. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 399. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 400. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 401. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 402. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 403. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 404. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 405. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 406. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 407. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 408. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 409. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 410. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 411. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 412. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 413. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 414. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 415. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 416. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 417. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 418. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 419. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 420. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 421. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 422. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 423. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 424. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 425. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 426. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 427. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 428. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 429. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 430. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 431. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 432. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 433. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 434. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 435. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 436. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 437. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 438. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 439. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 440. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 441. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 442. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 443. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 444. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 445. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 446. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 447. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 448. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 449. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 450. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 451. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 452. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 453. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 454. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 455. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 456. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 457. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 458. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 459. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 460. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 461. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 462. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 463. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 464. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 465. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 466. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 467. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 468. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 469. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 470. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 471. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 472. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 473. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 474. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 475. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 476. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 477. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 478. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 479. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 480. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 481. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 482. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 483. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 484. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 485. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 486. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 487. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 488. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 489. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 490. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 491. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 492. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 493. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 494. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 495. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 496. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 497. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 498. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 499. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 500. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 501. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 502. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 503. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 504. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 505. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 506. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 507. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 508. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 509. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 510. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 511. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 512. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 513. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 514. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 515. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 516. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 517. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 518. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 519. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 520. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 521. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 522. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 523. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 524. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 525. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 526. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 527. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 528. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 529. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 530. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 531. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 532. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 533. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 534. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 535. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 536. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 537. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 538. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 539. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 540. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 541. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 542. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 543. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 544. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 545. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 546. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 547. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 548. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 549. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 550. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 551. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 552. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 553. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 554. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 555. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 556. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 557. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 558. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 559. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 560. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 561. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 562. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 563. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 564. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 565. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 566. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 567. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 568. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 569. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 570. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 571. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 572. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 573. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 574. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 575. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 576. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 577. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 578. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 579. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 580. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 581. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 582. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 583. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 584. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 585. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 586. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 587. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 588. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 589. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 590. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 591. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 592. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 593. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 594. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 595. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 596. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 597. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 598. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 599. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 600. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 601. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 602. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 603. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 604. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 605. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 606. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 607. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 608. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 609. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 610. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 611. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 612. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 613. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 614. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 615. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 616. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 617. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 618. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 619. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 620. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 621. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 622. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 623. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 624. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 625. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 626. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 627. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 628. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 629. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 630. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 631. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 632. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 633. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 634. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 635. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 636. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 637. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 638. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 639. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 640. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 641. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 642. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 643. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 644. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 645. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 646. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 647. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 648. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 649. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 650. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 651. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 652. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 653. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 654. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 655. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 656. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 657. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 658. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 659. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 660. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 661. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 662. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 663. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 664. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 665. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 666. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 667. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 668. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 669. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 670. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 671. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 672. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 673. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 674. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 675. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 676. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 677. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 678. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 679. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 680. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 681. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 682. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 683. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 684. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 685. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 686. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 687. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 688. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 689. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 690. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 691. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 692. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 693. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 694. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 695. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 696. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 697. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 698. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 699. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 700. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 701. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 702. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 703. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 704. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 705. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 706. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 707. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 708. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 709. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 710. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 711. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 712. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 713. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 714. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 715. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 716. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 717. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 718. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 719. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 720. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 721. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 722. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 723. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 724. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 725. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 726. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 727. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 728. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 729. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 730. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 731. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 732. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 733. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 734. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 735. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 736. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 737. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 738. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 739. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 740. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 741. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 742. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 743. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 744. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 745. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 746. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 747. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 748. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 749. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 750. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 751. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 752. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 753. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 754. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 755. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 756. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 757. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 758. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 759. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 760. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 761. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 762. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 763. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 764. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 765. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 766. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 767. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 768. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 769. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 770. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 771. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 772. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 773. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 774. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 775. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 776. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 777. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 778. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 779. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 780. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 781. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 782. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 783. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 784. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 785. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 786. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 787. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 788. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 789. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 790. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 791. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 792. Leading 10 Beta Glucan Companies (Ranking, Company, Latest Total Company Sales US$M, HQ)
Table 793. Cargill Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 794. Cargill Inc. Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 795. Cargill Inc. Beta Glucan Product Offering (Segment, Product Offerings)
Table 796. Tate & Lyle Plc Profile 2019 (CEO, HQ, Founded, Website)
Table 797. Tate & Lyle Plc Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 798. Tate & Lyle Plc Beta Glucan Product Offering (Segment, Product Offerings)
Table 799. Kerry Group Plc Profile 2019 (CEO, HQ, Founded, Website)
Table 800. Kerry Group Plc Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 801. Kerry Group Plc Beta Glucan Product Offering (Segment, Product Offerings)
Table 802. Koninklijke DSM NV Profile 2019 (CEO, HQ, Founded, Website)
Table 803. Koninklijke DSM NV Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 804. Koninklijke DSM NV Beta Glucan Product Offering (Segment, Product Offerings)
Table 805. Frutarom Profile 2019 (CEO, HQ, Founded, Website)
Table 806. Frutarom Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 807. Frutarom Beta Glucan Product Offering (Segment, Product Offerings)
Table 808. Garuda International Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 809. Garuda International Inc. Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 810. Garuda International Inc. Beta Glucan Product Offering (Segment, Product Offerings)
Table 811. Ohly Profile 2019 (CEO, HQ, Founded, Website)
Table 812. Ohly Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 813. Ohly Beta Glucan Product Offering (Segment, Product Offerings)
Table 814. Milipore Sigma Profile 2019 (CEO, HQ, Founded, Website)
Table 815. Milipore Sigma Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 816. Milipore Sigma Beta Glucan Product Offering (Segment, Product Offerings)
Table 817. Super Beta Glucan Profile 2019 (CEO, HQ, Founded, Website)
Table 818. Super Beta Glucan Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 819. Super Beta Glucan Beta Glucan Product Offering (Segment, Product Offerings)
Table 820. Alltech Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 821. Alltech Inc. Beta Glucan Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 822. Alltech Inc. Beta Glucan Product Offering (Segment, Product Offerings)
LIST OF FIGURES
Figure 1. Beta Glucan Market Purity Overview
Figure 2. Beta Glucan Market Category Overview
Figure 3. Beta Glucan Market Source Overview
Figure 4. Beta Glucan Market End-use Industries Overview
Figure 5. Beta Glucan Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 6. Beta Glucan Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 7. Beta Glucan Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 8. Beta Glucan Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 9. Beta Glucan Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 10. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 11. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 12. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 13. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 14. Beta Glucan Submarket Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 15. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 16. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 17. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 18. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 19. Below 20% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 20. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 21. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 22. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 23. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 24. 20% to 30% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 25. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 26. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 27. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 28. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 29. 30% to 50% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 30. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 31. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 32. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 33. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 34. 50% to 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 35. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 36. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 37. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 38. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 39. Above 70% Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 40. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 41. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 42. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 43. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 44. Beta Glucan Submarket Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 45. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 46. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 47. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 48. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 49. Soluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 50. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 51. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 52. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 53. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 54. Insoluble Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 55. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 56. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 57. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 58. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 59. Beta Glucan Submarket Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 60. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 61. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 62. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 63. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 64. Cereals Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 65. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 66. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 67. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 68. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 69. Seaweed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 70. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 71. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 72. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 73. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 74. Yeast Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 75. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 76. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 77. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 78. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 79. Mushroom Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 80. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 81. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 82. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 83. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 84. Beta Glucan Submarket Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 85. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 86. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 87. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 88. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 89. Food & Beverages Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 90. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 91. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 92. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 93. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 94. Personal Care Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 95. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 96. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 97. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 98. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 99. Healthcare Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 100. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 101. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 102. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 103. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 104. Animal Feed Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 105. Regional Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 106. Regional Beta Glucan Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 107. Regional Beta Glucan Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 108. Regional Beta Glucan Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 109. Regional Beta Glucan Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 110. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 111. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 112. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 113. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 114. North America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 115. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 116. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 117. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 118. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 119. North America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 120. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 121. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 122. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 123. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 124. North America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 125. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 126. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 127. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 128. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 129. North America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 130. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 131. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 132. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 133. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 134. North America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 135. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 136. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 137. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 138. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 139. U.S. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 140. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 141. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 142. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 143. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 144. U.S. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 145. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 146. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 147. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 148. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 149. U.S. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 150. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 151. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 152. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 153. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 154. U.S. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 155. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 156. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 157. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 158. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 159. Canada Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 160. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 161. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 162. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 163. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 164. Canada Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 165. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 166. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 167. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 168. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 169. Canada Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 170. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 171. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 172. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 173. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 174. Canada Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 175. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 176. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 177. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 178. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 179. Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 180. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 181. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 182. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 183. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 184. Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 185. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 186. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 187. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 188. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 189. Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 190. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 191. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 192. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 193. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 194. Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 195. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 196. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 197. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 198. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 199. Europe Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 200. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 201. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 202. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 203. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 204. Germany Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 205. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 206. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 207. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 208. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 209. Germany Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 210. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 211. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 212. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 213. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 214. Germany Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 215. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 216. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 217. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 218. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 219. Germany Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 220. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 221. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 222. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 223. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 224. U.K. Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 225. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 226. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 227. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 228. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 229. U.K. Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 230. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 231. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 232. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 233. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 234. U.K. Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 235. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 236. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 237. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 238. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 239. U.K. Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 240. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 241. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 242. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 243. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 244. France Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 245. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 246. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 247. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 248. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 249. France Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 250. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 251. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 252. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 253. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 254. France Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 255. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 256. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 257. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 258. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 259. France Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 260. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 261. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 262. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 263. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 264. Italy Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 265. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 266. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 267. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 268. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 269. Italy Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 270. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 271. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 272. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 273. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 274. Italy Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 275. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 276. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 277. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 278. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 279. Italy Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 280. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 281. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 282. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 283. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 284. Spain Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 285. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 286. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 287. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 288. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 289. Spain Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 290. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 291. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 292. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 293. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 294. Spain Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 295. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 296. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 297. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 298. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 299. Spain Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 300. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 301. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 302. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 303. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 304. Russia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 305. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 306. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 307. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 308. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 309. Russia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 310. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 311. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 312. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 313. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 314. Russia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 315. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 316. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 317. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 318. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 319. Russia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 320. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 321. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 322. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 323. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 324. Netherlands Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 325. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 326. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 327. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 328. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 329. Netherlands Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 330. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 331. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 332. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 333. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 334. Netherlands Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 335. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 336. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 337. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 338. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 339. Netherlands Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 340. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 341. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 342. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 343. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 344. Rest of Europe Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 345. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 346. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 347. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 348. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 349. Rest of Europe Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 350. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 351. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 352. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 353. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 354. Rest of Europe Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 355. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 356. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 357. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 358. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 359. Rest of Europe Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 360. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 361. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 362. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 363. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 364. Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 365. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 366. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 367. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 368. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 369. Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 370. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 371. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 372. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 373. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 374. Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 375. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 376. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 377. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 378. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 379. Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 380. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 381. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 382. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 383. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 384. Asia Pacific Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 385. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 386. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 387. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 388. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 389. China Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 390. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 391. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 392. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 393. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 394. China Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 395. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 396. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 397. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 398. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 399. China Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 400. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 401. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 402. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 403. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 404. China Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 405. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 406. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 407. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 408. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 409. India Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 410. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 411. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 412. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 413. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 414. India Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 415. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 416. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 417. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 418. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 419. India Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 420. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 421. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 422. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 423. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 424. India Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 425. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 426. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 427. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 428. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 429. Japan Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 430. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 431. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 432. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 433. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 434. Japan Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 435. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 436. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 437. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 438. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 439. Japan Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 440. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 441. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 442. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 443. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 444. Japan Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 445. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 446. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 447. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 448. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 449. Australia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 450. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 451. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 452. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 453. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 454. Australia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 455. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 456. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 457. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 458. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 459. Australia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 460. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 461. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 462. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 463. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 464. Australia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 465. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 466. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 467. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 468. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 469. South Korea Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 470. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 471. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 472. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 473. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 474. South Korea Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 475. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 476. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 477. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 478. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 479. South Korea Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 480. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 481. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 482. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 483. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 484. South Korea Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 485. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 486. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 487. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 488. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 489. Southeast Asia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 490. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 491. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 492. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 493. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 494. Southeast Asia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 495. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 496. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 497. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 498. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 499. Southeast Asia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 500. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 501. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 502. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 503. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 504. Southeast Asia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 505. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 506. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 507. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 508. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 509. Rest of Asia Pacific Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 510. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 511. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 512. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 513. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 514. Rest of Asia Pacific Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 515. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 516. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 517. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 518. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 519. Rest of Asia Pacific Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 520. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 521. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 522. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 523. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 524. Rest of Asia Pacific Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 525. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 526. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 527. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 528. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 529. Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 530. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 531. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 532. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 533. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 534. Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 535. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 536. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 537. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 538. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 539. Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 540. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 541. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 542. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 543. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 544. Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 545. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 546. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 547. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 548. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 549. Latin America Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 550. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 551. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 552. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 553. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 554. Brazil Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 555. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 556. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 557. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 558. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 559. Brazil Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 560. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 561. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 562. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 563. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 564. Brazil Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 565. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 566. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 567. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 568. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 569. Brazil Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 570. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 571. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 572. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 573. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 574. Mexico Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 575. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 576. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 577. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 578. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 579. Mexico Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 580. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 581. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 582. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 583. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 584. Mexico Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 585. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 586. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 587. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 588. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 589. Mexico Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 590. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 591. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 592. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 593. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 594. Argentina Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 595. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 596. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 597. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 598. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 599. Argentina Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 600. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 601. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 602. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 603. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 604. Argentina Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 605. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 606. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 607. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 608. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 609. Argentina Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 610. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 611. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 612. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 613. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 614. Colombia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 615. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 616. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 617. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 618. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 619. Colombia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 620. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 621. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 622. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 623. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 624. Colombia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 625. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 626. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 627. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 628. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 629. Colombia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 630. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 631. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 632. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 633. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 634. Rest of Latin America Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 635. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 636. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 637. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 638. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 639. Rest of Latin America Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 640. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 641. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 642. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 643. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 644. Rest of Latin America Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 645. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 646. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 647. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 648. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 649. Rest of Latin America Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 650. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 651. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 652. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 653. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 654. Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 655. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 656. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 657. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 658. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 659. Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 660. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 661. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 662. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 663. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 664. Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 665. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 666. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 667. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 668. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 669. Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 670. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 671. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 672. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 673. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 674. Middle East & Africa Beta Glucan Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 675. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 676. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 677. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 678. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 679. Turkey Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 680. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 681. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 682. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 683. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 684. Turkey Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 685. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 686. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 687. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 688. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 689. Turkey Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 690. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 691. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 692. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 693. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 694. Turkey Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 695. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 696. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 697. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 698. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 699. Saudi Arabia Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 700. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 701. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 702. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 703. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 704. Saudi Arabia Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 705. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 706. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 707. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 708. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 709. Saudi Arabia Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 710. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 711. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 712. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 713. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 714. Saudi Arabia Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 715. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 716. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 717. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 718. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 719. South Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 720. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 721. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 722. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 723. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 724. South Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 725. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 726. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 727. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 728. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 729. South Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 730. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 731. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 732. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 733. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 734. South Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 735. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 736. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 737. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 738. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 739. UAE Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 740. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 741. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 742. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 743. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 744. UAE Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 745. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 746. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 747. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 748. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 749. UAE Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 750. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 751. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 752. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 753. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 754. UAE Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 755. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 756. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 757. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 758. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 759. Egypt Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 760. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 761. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 762. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 763. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 764. Egypt Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 765. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 766. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 767. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 768. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 769. Egypt Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 770. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 771. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 772. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 773. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 774. Egypt Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 775. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 776. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 777. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 778. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 779. Rest of Middle East & Africa Beta Glucan Market Forecast by Purity 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 780. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 781. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 782. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 783. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 784. Rest of Middle East & Africa Beta Glucan Market Forecast by Category 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 785. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 786. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 787. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 788. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 789. Rest of Middle East & Africa Beta Glucan Market Forecast by Source 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 790. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 791. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 792. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 793. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 794. Rest of Middle East & Africa Beta Glucan Market Forecast by End-use Industries 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 795. Porter’s Five Force Analysis
Figure 796. Cargill Inc. Total Company Sales 2015-2019 (US$m, AGR %)
Figure 797. Cargill Inc. Sales by Segment of Business 2019 (US$m)
Figure 798. Cargill Inc. Sales by Regional Segment of Business 2019 (US$m)
Figure 799. Tate & Lyle Plc Total Company Sales 2015-2019 (US$m, AGR %)
Figure 800. Tate & Lyle Plc Sales by Segment of Business 2019 (US$m)
Figure 801. Tate & Lyle Plc Sales by Regional Segment of Business 2019 (US$m)
Figure 802. Kerry Group Plc Total Company Sales 2015-2019 (US$m, AGR %)
Figure 803. Kerry Group Plc Sales by Segment of Business 2019 (US$m)
Figure 804. Kerry Group Plc Sales by Regional Segment of Business 2019 (US$m)
Figure 805. Koninklijke DSM NV Total Company Sales 2015-2019 (US$m, AGR %)
Figure 806. Koninklijke DSM NV Sales by Segment of Business 2019 (US$m)
Figure 807. Koninklijke DSM NV Sales by Regional Segment of Business 2019 (US$m)
Figure 808. Frutarom Total Company Sales 2015-2019 (US$m, AGR %)
Figure 809. Frutarom Sales by Segment of Business 2019 (US$m)
Figure 810. Frutarom Sales by Regional Segment of Business 2019 (US$m)
Figure 811. Garuda International Inc. Total Company Sales 2015-2019 (US$m, AGR %)
Figure 812. Garuda International Inc. Sales by Segment of Business 2019 (US$m)
Figure 813. Garuda International Inc. Sales by Regional Segment of Business 2019 (US$m)
Figure 814. Ohly Total Company Sales 2015-2019 (US$m, AGR %)
Figure 815. Ohly Sales by Segment of Business 2019 (US$m)
Figure 816. Ohly Sales by Regional Segment of Business 2019 (US$m)
Figure 817. Milipore Sigma Total Company Sales 2015-2019 (US$m, AGR %)
Figure 818. Milipore Sigma Sales by Segment of Business 2019 (US$m)
Figure 819. Milipore Sigma Sales by Regional Segment of Business 2019 (US$m)
Figure 820. Super Beta Glucan Total Company Sales 2015-2019 (US$m, AGR %)
Figure 821. Super Beta Glucan Sales by Segment of Business 2019 (US$m)
Figure 822. Super Beta Glucan Sales by Regional Segment of Business 2019 (US$m)
Figure 823. Alltech Inc. Total Company Sales 2015-2019 (US$m, AGR %)
Figure 824. Alltech Inc. Sales by Segment of Business 2019 (US$m)
Figure 825. Alltech Inc. Sales by Regional Segment of Business 2019 (US$m)
Companies Profiled in the Report
1. Cargill Inc.
2. Tate & Lyle Plc
3. Kerry Group Plc
4. Koninklijke DSM NV
5. Frutarom
6. Garuda International Inc.
7. Ohly
8. Millipore Sigma
9. Super Beta Glucan
10. Alltech Inc.
Companies Mentioned in the Report
1. Lesaffre Human Care
2. Biotec Pharmacon ASA
3. Biothera Pharmaceuticals
4. Ceapro Inc.
5. Immunomedic AS
6. Groupe Soufflet SA
7. Zilor Inc.
8. Glycanova AS
9. AIT Ingredients
10. Angel Yeast Co. Ltd.
11. Biorigin
12. Sigma Aldrich
13. Specialty Biotech
1. Cargill Inc.
2. Tate & Lyle Plc
3. Kerry Group Plc
4. Koninklijke DSM NV
5. Frutarom
6. Garuda International Inc.
7. Ohly
8. Millipore Sigma
9. Super Beta Glucan
10. Alltech Inc.
Companies Mentioned in the Report
1. Lesaffre Human Care
2. Biotec Pharmacon ASA
3. Biothera Pharmaceuticals
4. Ceapro Inc.
5. Immunomedic AS
6. Groupe Soufflet SA
7. Zilor Inc.
8. Glycanova AS
9. AIT Ingredients
10. Angel Yeast Co. Ltd.
11. Biorigin
12. Sigma Aldrich
13. Specialty Biotech
Download sample pages
Complete the form below to download your free sample pages for Beta Glucan Market Report to 2031Download sample pages
Complete the form below to download your free sample pages for Beta Glucan Market Report to 2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice? If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain food & drink reports are compiled using a broad and rich mixture of both primary and secondary information to produce an overall industry outlook. In order to provide our clients with the best product possible product, we do not rely on any one single source of information. Visiongain analysts reach out to market-leading vendors, carriers, service providers and industry experts but also review a wealth of financial data and product information from a vast range of sources. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Would you like to get the latest Visiongain food & drink reports catalogue? What are the dynamic growth sectors? where are the regional business opportunities? Which technologies will prevail and who are the leading companies succeeding in these sectors and why? If you want definitive answers to business critical questions, discover Visiongain’s full range of business intelligence reports. If so, please email Sara Peerun on sara.peerun@visiongain.com or call her today on +44 (0) 20 7549 9987
Assured Food Standards
Europatat
Federation of Oils, Seeds and Fats Associations
Food and Drink Federation
Food & Drink Federation
Grain and Feed Trade Association
Freshfel Europe
International Dairy-Deli-Bakery Association
Meat Industry Association of New Zealand
National Frozen & Refrigerated Foods Association
Produce Marketing Association
TURYID
U.S. Poultry & Egg Association
Visiongain Food & Drink
Visiongain Food & Drink
Visiongain Food & DrinkLatest Food and Drink news
Visiongain Publishes Vegetable Oil Market Report 2023-2033
The global Vegetable Oil market was valued at US$323.18 billion in 2022 and is projected to grow at a CAGR of 6.2% during the forecast period 2023-2033.
25 May 2023
Visiongain Publishes Commercial Greenhouse Market Report 2023-2033
The global Commercial Greenhouse market was valued at US$36.2 billion in 2022 and is projected to grow at a CAGR of 11.4% during the forecast period 2023-2033.
15 May 2023
Visiongain Publishes Modified Starch Market Report 2023-2033
The global Modified Starch market was valued at US$12.8 billion in 2022 and is projected to grow at a CAGR of 3.3% during the forecast period 2023-2033.
09 May 2023
Visiongain Publishes Food High Pressure Processing (HPP) Equipment Market Report 2023-2033
The global Food High Pressure Processing (HPP) Equipment market was valued at US$242.9 million in 2022 and is projected to grow at a CAGR of 15.86% during the forecast period 2023-2033.
19 April 2023
